49 related articles for article (PubMed ID: 8158846)
21. Autografting Ph-negative blood precursor cells in chronic myeloid leukaemia.
Frassoni F; Giordano D; Podestà M; Piaggio G; Benvenuto F; Pitto A; Figari O; Dejana A; Lerma E; Vassallo F; Sessarego M; Carella A
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S59-62. PubMed ID: 8769704
[TBL] [Abstract][Full Text] [Related]
22. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Matsue K; Tabayashi T; Yamada K; Takeuchi M
Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
[TBL] [Abstract][Full Text] [Related]
23. Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group.
Simonsson B; Oberg G; Björeman M; Björkholm M; Carneskog J; Gahrton G; Hast R; Karl H; Lanng-Nielsen J; Löfvenberg E; Malm C; Turesson I; Udén AM; Vilén L; Weis-Bjerrum O
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S63-4. PubMed ID: 8769705
[TBL] [Abstract][Full Text] [Related]
24. [Cytogenetic analysis and bcr/abl mRNA detection in chronic myeloid leukemia].
Yao B; Guo M; Pian H
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):137-9. PubMed ID: 11601240
[TBL] [Abstract][Full Text] [Related]
25. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Rios MB; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Wierda W; Keating M; Talpaz M
Cancer; 2003 Dec; 98(12):2636-42. PubMed ID: 14669283
[TBL] [Abstract][Full Text] [Related]
26. Chronic myelogenous leukemia: does interferon alpha prolong life?
Hehlmann R
Leukemia; 1996 Feb; 10(2):193-6. PubMed ID: 8637225
[No Abstract] [Full Text] [Related]
27. Interferon alfa therapy in an infant with juvenile chronic myelogenous leukemia.
Toraldo R; Vetrano F; Pistoia V; Tolone C; Canino G; D'Avanzo M; Iafusco F
Pediatr Hematol Oncol; 1995; 12(2):189-94. PubMed ID: 7626389
[TBL] [Abstract][Full Text] [Related]
28. [Interferon-alpha therapy in chronic myeloid leukemia].
Lutz D
Wien Med Wochenschr; 1993; 143(16-17):416-9. PubMed ID: 8273364
[TBL] [Abstract][Full Text] [Related]
29. [Value of interferon-alpha in treatment of chronic myeloid leukemia].
Thaler J
Acta Med Austriaca; 1993; 20(3):65-9. PubMed ID: 8368048
[TBL] [Abstract][Full Text] [Related]
30. [Molecular diagnosis and therapeutic strategy for Philadelphia chromosome-positive acute leukemia].
Kawakubo K; Ohyashiki JH; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1994 Mar; 35(3):261-6. PubMed ID: 8158846
[TBL] [Abstract][Full Text] [Related]
31. [Molecular implication of Ph positive leukemias: treatment with alpha-interferon in Ph positive acute leukemia].
Ohyashiki JH; Kawakubo K; Ohyashiki K; Toyama K
Rinsho Byori; 1993 Dec; 41(12):1305-9. PubMed ID: 8295339
[TBL] [Abstract][Full Text] [Related]
32. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
33. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
34. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
[TBL] [Abstract][Full Text] [Related]
35. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
Schulze E; Krahl R; Thalmeier K; Helbig W
Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
